XCath

Houston surgical-robotics company (founded 2017) developing endovascular robotic systems and steerable guidewires for neurovascular care. Its EVR system achieved first-in-human intracranial navigation, treating complex brain aneurysms, and it has demonstrated telerobotic mechanical thrombectomy. Raised a $30M Series C in 2026 backed by Intuitive Surgical founder Dr. Fred Moll (~$92M total). Campuses in Houston and Pangyo, South Korea.